BIOGEN PHARMACHEM INDUSTRIES LIMITED : BOARD MEETING HELD ON NOV 3, 2026

• Board considered and approved unaudited financial results for the quarter and half year ended September 30, 2026 • Board meeting commenced at 02:30 PM and concluded at 03:00 PM • The company's net profit for the quarter was ₹25.73 lakh, and for the half year it was ₹47.87 lakh. • Total comprehensive income for the quarter was ₹25.73 lakh, and for the half year it was ₹47.87 lakh. Impact: Neutral (Routine board meeting outcome and unaudited results disclosure)

Biogen Pharmachem Industries Ltd

Open attachment

← Back to feed